MPR Weekly Dose Podcast #152

Catch up on drug news with the latest MPR podcast.

COVID-19 booster dose authorized for those aged 6 months through 4 years; Rapid STI point-of-care test for women is cleared; Rett syndrome therapy and migraine treatment approved; and the Oncology Drugs Advisory Committee takes a vote on a drug combination treatment for diffuse large B-cell lymphoma.